MASScot does not endorse nor is affiliated with any of the content contained within these links.
- Two Bristol-Myers Squibb drugs approved by Scottish Medicines Consortium
Yervoy (ipilimumab), has been accepted for use in adult patient in Scotland with previously-untreated advanced melanoma. Data has shown ipilimumab has the potential to improve the overall survival of some patients with unreselectable or metastatic melanoma, whether they have received prior therapy or not.
Source: The Pharma Letter
- Thin melanomas cause greater number of deaths
More people are dying from melanomas thinner than a dime than from the thicker cancerous skin lesions long thought to be more dangerous, according to a new study from Queensland, Australia.
Source: Reuters
- Melanoma Risk Genetic Testing May Help With Prevention
Positive genetic risk information about melanoma may help to prompt people to discuss melanoma risk with a wider variety of family members, according to a study published in JAMA that examined the effects of hypothetical genetic testing. Interestingly, even people who received negative genetic testing results were still affected by the results.
Source: Cancer Network
- MelaFind: Spotting Melanoma Without a Biopsy
More than 76-thousand Americans will be diagnosed with melanoma this year. If it’s not caught early, this type of skin cancer can be deadly. Doctors used to rely on biopsies to make a diagnosis, but now there’s a much less painful way. Spotting melanoma is easier than ever.
Source: Ksat
- Next-Gen Melanoma Drug Excels in Lab Tests
A University of Colorado Cancer Center study published online in the journal Molecular Cancer Therapeutics reports anti-cancer activity in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733, a small molecule inhibitor of MEK1/2. While the drug is conceived as a second-generation inhibitor in patients harboring the BRAF mutation, the study shows drug activity in melanoma models regardless of BRAF mutation status. Treated tumors shrunk up to 100%.
Source: DDD Mag
- High tech treatment of that "skin" cancer, Melanoma
A blog from Donna Jeanne for Chicago Now. Donna is a Stage IV Melanoma patient who's goal is to teach others about the dangers of melanoma and the best protection.
Source: Chicago Now
- This App Can Detect Skin Cancer In 7 Out Of 10 Cases: Here's How It Works
Treating melanoma in the UK costs more than £100 million every year, but the skin cancer can be treated easily and at less cost if detected in advance. An app developed by a team from Romania's University of Bucharest, called SkinVision, provides a new weapon against the disease, with an ability to detect melanoma with an accuracy of 73% using only a picture.
Source: UK Business Insider
- Richie Benaud: Cricket commentator receiving radiation treatment for skin cancer
Cricket commentator Richie Benaud has revealed that he’s receiving radiation therapy to treat skin cancer just a year after he suffered serious injuries following a car crash.
Source: Independent
- Skin Cancer Costs Soar Compared to Other Malignancies: CDC
The cost of skin cancer treatment in the United States more than doubled between 2002 and 2011, and rose five times faster than treatments for other cancers, a new study found.
Source: Consumer Healthday
No comments:
Post a Comment